Funder: Novo Nordisk
Due Dates (Anticipated): October 2026 (full application deadline, projected)
Funding Amounts: DKK 40–75 million (approx. EUR 5.4–10 million) per grant; project duration up to 6 years
Summary: Supports collaborative research to develop innovative models for human cardiometabolic disease, aiming to improve translation of scientific findings into clinical practice.
Key Information: Large, consortium-based grants; at least one partner must be based in Denmark; industry partners may participate but cannot receive funding.